ClinicalTrials.gg
Drug

Urokinase-Type Plasminogen Activator clinical trials

Also written Urokinase.

studies test it
11
open now
1
in phase 3
6
first study started
2002

How each study uses Urokinase-Type Plasminogen Activator is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Urokinase-Type Plasminogen Activator studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
16 Jan 1978 · KINLYTIC · BLA 021846 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Urokinase-type plasminogen activator
1

Other names

Urokinase
10

Studies by the year they started

11 studies that test it; most in 2002 (2)

Studies that test Urokinase-Type Plasminogen Activator, by start year
YearStudies
20022
20071
20082
20101
20111
20141
20202
20241

By phase

A phase 1/2 study counts in both.

Phase 2
2
Phase 3
6
Phase 4
4

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 2 · Other 9

medac GmbH (2) · National Healthcare Group, Singapore (1) · The First Affiliated Hospital of Zhengzhou University (1) · Spanish Society of Pediatric Surgery (1) · Beijing Chao Yang Hospital (1) · Second Affiliated Hospital of Nanchang University (1) · GWT-TUD GmbH (1) · University of Roma La Sapienza (1)

Often tested with

Tested in the same studies.

Dornase alfa (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test Urokinase-Type Plasminogen Activator.

Studies

Open first, then newest update. How each study uses Urokinase-Type Plasminogen Activator is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 11

Given beside what is tested · 1 — Urokinase-Type Plasminogen Activator is usual care or a partner of the new treatment
As the comparator · 1 — what is tested is compared with Urokinase-Type Plasminogen Activator

Codes

What other systems call Urokinase-Type Plasminogen Activator · ClinicalTrials.gg INT008388

  • UNII (FDA) 83G67E21XIUROKINASEConfirmed FDA, Wikidata
  • RxNorm 11055Confirmed FDA, Wikidata
  • Wikidata Q110969665urokinaseConfirmed FDA, Wikidata
  • DrugBank DB00013One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.